Article
OGDHL Expression as a Prognostic Biomarker for Liver Cancer Patients
17 Oct 2019
Abstract excerpt
Background and Objective. Liver cancer is a highly malignant tumor, and patients typically have poor prognoses. Metabolic reprogramming is a hallmark of cancer, and downregulation of oxoglutarate dehydrogenase-like (OGDHL) contributes to the onset and progression of several cancers. We examined the role of altered OGDHL expression in liver cancer and determined its value as a diagnostic and prognostic indicator...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
